1. Home
  2. NVGS vs PHAR Comparison

NVGS vs PHAR Comparison

Compare NVGS & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navigator Holdings Ltd. (Marshall Islands)

NVGS

Navigator Holdings Ltd. (Marshall Islands)

HOLD

Current Price

$22.82

Market Cap

1.3B

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.91

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVGS
PHAR
Founded
1997
1988
Country
United Kingdom
Netherlands
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
NVGS
PHAR
Price
$22.82
$12.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$21.50
$38.33
AVG Volume (30 Days)
357.7K
8.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.30%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
N/A
$2.51
P/E Ratio
$13.06
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$13.50
$8.69
52 Week High
$23.22
$21.34

Technical Indicators

Market Signals
Indicator
NVGS
PHAR
Relative Strength Index (RSI) 69.68 28.24
Support Level $17.38 $11.02
Resistance Level N/A $17.79
Average True Range (ATR) 0.70 0.36
MACD 0.15 -0.47
Stochastic Oscillator 87.58 17.81

Price Performance

Historical Comparison
NVGS
PHAR

About NVGS Navigator Holdings Ltd. (Marshall Islands)

Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). The company plays a vital role in the globalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users, and commodity traders.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: